open access

Vol 8 (2023): Continuous Publishing
Original paper
Published online: 2023-11-16
Get Citation

Presentation of retinopathy of prematurity and associated risk factors in a referral center in Iraq

Ali Mohammed Abdulsahib1, Najah Kadhum Mohammad2, Haider Abdulkareem Aljanabi3
·
Ophthalmol J 2023;8:107-117.
Affiliations
  1. Middle Technical University, Al-Zafarania, Baghdad, Iraq
  2. Baghdad University, College of Medicine, Baghdad, Iraq
  3. Al-Shaheed Ghazi Al-Hariri Hospital for Surgical Specialties, Bab-Almuadam, Baghdad, Iraq

open access

Vol 8 (2023): Continuous Publishing
ORIGINAL PAPERS
Published online: 2023-11-16

Abstract

BACKGROUND: The aim of the study was to report the prevalence of retinopathy of prematurity (ROP) and its classification in a sample of premature Iraqi newborns and to investigate the associated risk factors.

MATERIAL AND METHODS: An observational retrospective cohort study carried out at the Ophthalmology Department, Hemayat Al-Tifil Hospital, Medical City Complex in Baghdad, Iraq. The data were collected from patients’ case files from December 2019 until the end of March 2021, targeting premature newborns with gestational age < 37 weeks who had dilated fundus examination and completed the follow-up.

RESULTS: During the study period, 269 cases were enrolled with a mean gestational age of 31.3 ± 2.2 weeks, 9.3% aged less than 28 weeks, and a birth weight of 1558.7 ± 476.8 grams. From the total sample, 19 (7.1%) had type 1 ROP (T1ROP), 43 (16%) had type 2 ROP (T2ROP), and 70 (26%) had any ROP. T1ROP was significantly associated with low gestational age (16% of cases aged < 28 weeks), respiratory distress syndrome (20%), and low birth weight (21.4% in cases with birth weight less than 1051 g). In multivariate regression analysis, poor weight gain maintained a statistically significant association with T1ROP.

CONCLUSION: The incidence of T1ROP in the study sample was comparable to results in other countries. Factors that were associated with increased risk for ROP after multivariate analysis were only poor weight gain.

 

 

Abstract

BACKGROUND: The aim of the study was to report the prevalence of retinopathy of prematurity (ROP) and its classification in a sample of premature Iraqi newborns and to investigate the associated risk factors.

MATERIAL AND METHODS: An observational retrospective cohort study carried out at the Ophthalmology Department, Hemayat Al-Tifil Hospital, Medical City Complex in Baghdad, Iraq. The data were collected from patients’ case files from December 2019 until the end of March 2021, targeting premature newborns with gestational age < 37 weeks who had dilated fundus examination and completed the follow-up.

RESULTS: During the study period, 269 cases were enrolled with a mean gestational age of 31.3 ± 2.2 weeks, 9.3% aged less than 28 weeks, and a birth weight of 1558.7 ± 476.8 grams. From the total sample, 19 (7.1%) had type 1 ROP (T1ROP), 43 (16%) had type 2 ROP (T2ROP), and 70 (26%) had any ROP. T1ROP was significantly associated with low gestational age (16% of cases aged < 28 weeks), respiratory distress syndrome (20%), and low birth weight (21.4% in cases with birth weight less than 1051 g). In multivariate regression analysis, poor weight gain maintained a statistically significant association with T1ROP.

CONCLUSION: The incidence of T1ROP in the study sample was comparable to results in other countries. Factors that were associated with increased risk for ROP after multivariate analysis were only poor weight gain.

 

 

Get Citation

Keywords

ROP; retinopathy; prematurity; G-ROP

About this article
Title

Presentation of retinopathy of prematurity and associated risk factors in a referral center in Iraq

Journal

Ophthalmology Journal

Issue

Vol 8 (2023): Continuous Publishing

Article type

Original paper

Pages

107-117

Published online

2023-11-16

Page views

329

Article views/downloads

130

DOI

10.5603/oj.95081

Bibliographic record

Ophthalmol J 2023;8:107-117.

Keywords

ROP
retinopathy
prematurity
G-ROP

Authors

Ali Mohammed Abdulsahib
Najah Kadhum Mohammad
Haider Abdulkareem Aljanabi

References (48)
  1. Retinopathy of Prematurity. In: McCannel CA, Berrocal AM, Holder GE. ed. 2020–2021 Basic And Clinical Science Course (Bcsc), Section 12: Retina And Vitreous. American Academy of Ophthalmology 2020.
  2. Heidar H, Miller AM, Stevenson E, et al. Retinopathy of Prematurity. https://eyewiki.aao.org/Retinopathy_of_Prematurity (2020).
  3. Stoltz Sjöström E, Lundgren P, Öhlund I, et al. Low energy intake during the first 4 weeks of life increases the risk for severe retinopathy of prematurity in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2016; 101(2): F108–F113.
  4. Ying GS, Quinn GE, Wade KC, et al. e-ROP Cooperative Group. Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. JAMA Ophthalmol. 2015; 133(3): 304–311.
  5. Mohsen L, Abou-Alam M, El-Dib M, et al. A prospective study on hyperglycemia and retinopathy of prematurity. J Perinatol. 2014; 34(6): 453–457.
  6. Kaempf JW, Kaempf AJ, Wu Y, et al. Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol. 2011; 31(4): 251–257.
  7. Chavez-Valdez R, McGowan J, Cannon E, et al. Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants. J Perinatol. 2011; 31(12): 749–756.
  8. Bharwani SK, Green BF, Pezzullo JC, et al. Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol. 2016; 36(11): 913–920.
  9. Zhou J, Shukla VV, John D, et al. Human Milk Feeding as a Protective Factor for Retinopathy of Prematurity: A Meta-analysis. Pediatrics. 2015; 136(6): e1576–e1586.
  10. Bharwani SK, Dhanireddy R. Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review. J Perinatol. 2008; 28(1): 61–66.
  11. Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009; 127(5): 622–627.
  12. Hellström A, Hård AL, Engström E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009; 123(4): e638–e645.
  13. Lai T.Y., Nagpal M., Bhaleeya S.D. et al. Retinopathy of Prematurity-Asia Pacific. 2013. https://www.aao.org/topic-detail/retinopathy-of-prematurity--asia-pacific (2013).
  14. Iturralde J. RetCam vs. Binocular Indirect Ophthalmoscopy for ROP Screening. EC Ophthalmology . 2017; 4(6): 625–626.
  15. Child and Adolescent Health Service. Retinopathy of Prematurity (ROP) Screening, Treatment and Ophthalmology Consultations. https://www.cahs.health.wa.gov.au/-/media/HSPs/CAHS/Documents/Health-Professionals/Neonatology-guidelines/Retinopathy-of-Prematurity-Screening-Treatment-Opthalmology-Consultations.pdf (2021).
  16. Wongwai P, Suwannaraj S, Asawaphureekorn S. Diagnostic accuracy of a digital fundus photographic system for detection of retinopathy of prematurity requiring treatment (ROP-RT). PLoS One. 2018; 13(7): e0201544.
  17. Sekeroglu MA, Hekimoglu E, Sekeroglu HT, et al. Alternative methods for the screening of retinopathy of prematurity: binocular indirect ophthalmoscopy vs wide-field digital retinal imaging. Eye (Lond). 2013; 27(9): 1053–1057.
  18. Binenbaum G, Tomlinson LA. Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics. Ophthalmic Epidemiol. 2017; 24(1): 36–47.
  19. Binenbaum G, Bell EF, Donohue P, et al. G-ROP Study Group. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol. 2018; 136(9): 1034–1040.
  20. Binenbaum G, Tomlinson LA, de Alba Campomanes AG, et al. Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020; 138(1): 31–37.
  21. Fierson WM. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptisis. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics. 2018; 142(6).
  22. Lin L, Binenbaum G. Postnatal weight gain and retinopathy of prematurity. Semin Perinatol. 2019; 43(6): 352–359.
  23. Mahmood NQ, Alameedy H, Almaroof SQ. The Incidence of Retinopathy of Prematurity at Al Zahraa Teaching Hospital at Al Najaf. Diyala J Med. 2019; 17(2): 182–188.
  24. Ludwig CA, Chen TA, Hernandez-Boussard T, et al. The Epidemiology of Retinopathy of Prematurity in the United States. Ophthalmic Surg Lasers Imaging Retina. 2017; 48(7): 553–562.
  25. World Health Organization. Preterm birth. https://www.who.int/news-room/fact-sheets/detail/preterm-birth#:~:text=There%20is%20a%20dramatic%20difference,die%20in%20high%2Dincome%20settings (2018).
  26. World Health Organization. Framework for health information systems and core indicators for monitoring health situation and health system performance 2015. http://applications.emro.who.int/dsaf/EMROPUB_2015_EN_1904.pdf?ua=1&ua=1 (2015).
  27. Araz-Ersan B, Kir N, Akarcay K, et al. Epidemiological analysis of retinopathy of prematurity in a referral centre in Turkey. Br J Ophthalmol. 2013; 97(1): 15–17.
  28. Kang EYC, Lien R, Wang NK, et al. Retinopathy of Prematurity Trends in Taiwan: A 10-Year Nationwide Population Study. Invest Ophthalmol Vis Sci. 2018; 59(8): 3599–3607.
  29. AlBalawi HB, AlBalawi NS, AlSuhaimi NA, et al. Incidence and Risk Factors for Retinopathy of Prematurity in Tabuk City, KSA. Middle East Afr J Ophthalmol. 2020; 27(2): 105–109.
  30. Jacob MK, Sawardekar KP, Ayoub HG, et al. Validation of the existing modified screening criteria for detection of all cases of Retinopathy of Prematurity in preterm babies - 11 year study from a governorate referral hospital in Oman. Saudi J Ophthalmol. 2016; 30(1): 3–8.
  31. Ali AA, Gomaa NAS, Awadein AR, et al. Retrospective cohort study shows that the risks for retinopathy of prematurity included birth age and weight, medical conditions and treatment. Acta Paediatr. 2017; 106(12): 1919–1927.
  32. Roohipoor R, Karkhaneh R, Farahani A, et al. Retinopathy of prematurity screening criteria in Iran: new screening guidelines. Arch Dis Child Fetal Neonatal Ed. 2016; 101(4): F288–F293.
  33. Grang P, Kaur P, Singh K, et al. Clinical profile on incidence and course of Retinopathy of Prematurity in a tertiary care hospital of Northern India. Asian J Med Sci. 2021; 12(7): 37–41.
  34. Holmström G, Tornqvist K, Al-Hawasi A, et al. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018; 96(2): 142–148.
  35. Hong EH, Shin YUn, Bae GiH, et al. Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data. Sci Rep. 2021; 11(1): 1451.
  36. Wu C, Vanderveen DK, Hellström A, et al. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010; 128(4): 443–447.
  37. Eckert GU, Fortes Filho JB, Maia M, et al. A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye (Lond). 2012; 26(3): 400–406.
  38. Binenbaum G, Ying GS, Quinn GE, et al. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol. 2012; 130(12): 1560–1565.
  39. Cao JH, Wagner BD, McCourt EA, et al. The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm. J AAPOS. 2016; 20(1): 19–24.
  40. McCourt EA, Ying GS, Lynch AM, et al. G-ROP Study Group. Validation of the Colorado Retinopathy of Prematurity Screening Model. JAMA Ophthalmol. 2018; 136(4): 409–416.
  41. Chaves-Samaniego MJ, Chaves-Samaniego MC, Muñoz Hoyos A, et al. New evidence on the protector effect of weight gain in retinopathy of prematurity. An Pediatr (Engl Ed). 2021; 95(2): 78–85.
  42. Bal S, Ying GS, Tomlinson L, et al. Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Association of Weight Gain Acceleration With Risk of Retinopathy of Prematurity. JAMA Ophthalmol. 2019; 137(11): 1301–1305.
  43. Lyu Z, Mao J, Chen Y, et al. Association between postnatal weight gain and severe retinopathy of prematurity in preterm babies with very low birth weight. Chin J Ocular Fundus Dis. 2016; 32: 172–176.
  44. Jensen AK, Ying GS, Huang J, et al. Postnatal Serum Insulin-like Growth Factor 1 and Retinopathy of Prematurity. Retina. 2017; 37(5): 867–872.
  45. Hellström A, Smith LEH, Dammann O. Retinopathy of prematurity. Lancet. 2013; 382(9902): 1445–1457.
  46. Ahmed ISH, Aclimandos W, Azad N, et al. The Postnatal Growth and Retinopathy of Prematurity Model: A Multi-institutional Validation Study. Ophthalmic Epidemiol. 2022; 29(3): 296–301.
  47. Yabas Kiziloglu O, Coskun Y, Akman I. Assessment of the G-ROP study criteria for predicting retinopathy of prematurity: results from a tertiary centre in Turkey. Int Ophthalmol. 2020; 40(7): 1647–1652.
  48. Caruggi S, Scaramuzzi M, Calevo MG, et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria: A retrospective Italian analysis. Eur J Ophthalmol. 2021 [Epub ahead of print]: 11206721211011362.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl